rs551990619

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_178452.6(DNAAF1):​c.112G>A​(p.Gly38Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,548,882 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G38A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00064 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 39 hom. )

Consequence

DNAAF1
NM_178452.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0100

Publications

4 publications found
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025403202).
BP6
Variant 16-84145552-G-A is Benign according to our data. Variant chr16-84145552-G-A is described in ClinVar as Benign. ClinVar VariationId is 215544.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000643 (98/152320) while in subpopulation SAS AF = 0.0199 (96/4834). AF 95% confidence interval is 0.0166. There are 2 homozygotes in GnomAd4. There are 73 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF1NM_178452.6 linkc.112G>A p.Gly38Ser missense_variant Exon 1 of 12 ENST00000378553.10 NP_848547.4 Q8NEP3-1A0A140VJN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF1ENST00000378553.10 linkc.112G>A p.Gly38Ser missense_variant Exon 1 of 12 1 NM_178452.6 ENSP00000367815.5 Q8NEP3-1
DNAAF1ENST00000567918.5 linkn.112G>A non_coding_transcript_exon_variant Exon 1 of 7 1 ENSP00000455154.1 H3BP51
DNAAF1ENST00000563093.5 linkn.112G>A non_coding_transcript_exon_variant Exon 1 of 11 2 ENSP00000457373.1 Q8NEP3-3
DNAAF1ENST00000570298.5 linkn.266G>A non_coding_transcript_exon_variant Exon 1 of 11 2

Frequencies

GnomAD3 genomes
AF:
0.000644
AC:
98
AN:
152202
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0198
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00296
AC:
446
AN:
150732
AF XY:
0.00416
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000812
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000740
Gnomad NFE exome
AF:
0.0000175
Gnomad OTH exome
AF:
0.000922
GnomAD4 exome
AF:
0.00120
AC:
1679
AN:
1396562
Hom.:
39
Cov.:
31
AF XY:
0.00177
AC XY:
1221
AN XY:
688968
show subpopulations
African (AFR)
AF:
0.0000630
AC:
2
AN:
31760
American (AMR)
AF:
0.0000560
AC:
2
AN:
35696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25152
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36086
South Asian (SAS)
AF:
0.0200
AC:
1581
AN:
79232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47480
Middle Eastern (MID)
AF:
0.000700
AC:
3
AN:
4284
European-Non Finnish (NFE)
AF:
0.0000111
AC:
12
AN:
1079010
Other (OTH)
AF:
0.00137
AC:
79
AN:
57862
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
97
193
290
386
483
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000643
AC:
98
AN:
152320
Hom.:
2
Cov.:
32
AF XY:
0.000980
AC XY:
73
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0000240
AC:
1
AN:
41584
American (AMR)
AF:
0.00
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.0199
AC:
96
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000128
Hom.:
0
Bravo
AF:
0.000121
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.00232
AC:
206
Asia WGS
AF:
0.0180
AC:
62
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
7.0
DANN
Benign
0.72
DEOGEN2
Benign
0.0037
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.040
N
LIST_S2
Benign
0.52
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L
PhyloP100
-0.010
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.53
N
REVEL
Benign
0.013
Sift
Benign
0.50
T
Sift4G
Benign
0.83
T
Polyphen
0.0060
B
Vest4
0.077
MutPred
0.074
Gain of phosphorylation at G38 (P = 0.0077);
MVP
0.040
MPC
0.020
ClinPred
0.0052
T
GERP RS
-0.93
PromoterAI
-0.050
Neutral
Varity_R
0.030
gMVP
0.17
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs551990619; hg19: chr16-84179157; API